Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rusul Al-Marayaty

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cell Reports. Medicine|August 16, 2023
Pushing forward in sarcoma with a new TCR targeting NY-ESO-1Rusul Al-Marayaty, Seth M Pollack
Current Oncology Reports|March 17, 2026
Revisiting the Immune Frontier in Soft Tissue SarcomasNadeem Bilani, Nourhane Al Akoum, Rusul Al-Marayaty, et al.
Journal of Cancer Research and Clinical Oncology|February 10, 2025
Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotinJohn S Wang, Jack C Shapiro, Sarah Orlando, et al.
Clinical Medicine Insights. Oncology|June 23, 2025
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From SurgeryJohn S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
Cancer Immunology Research|February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Frontiers in Oncology|June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case seriesJessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Cancer Discovery|April 22, 2026
BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCERBrett A Schroeder, Chirayu Mohindroo, Anna-Lena Meinhardt, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cell Reports. Medicine|August 16, 2023
Pushing forward in sarcoma with a new TCR targeting NY-ESO-1Rusul Al-Marayaty, Seth M Pollack
Current Oncology Reports|March 17, 2026
Revisiting the Immune Frontier in Soft Tissue SarcomasNadeem Bilani, Nourhane Al Akoum, Rusul Al-Marayaty, et al.
Journal of Cancer Research and Clinical Oncology|February 10, 2025
Durable response to treatment of an atypical desmoplastic small round cell tumor with enfortumab-vedotinJohn S Wang, Jack C Shapiro, Sarah Orlando, et al.
Clinical Medicine Insights. Oncology|June 23, 2025
Primary Management of Localized Gastrointestinal Stromal Tumors With Imatinib Monotherapy: An Alternative to Resection of Patients Precluded From SurgeryJohn S Wang, Brandon L Ellsworth, Rusul Al-Marayaty, et al.
BMC Cancer|October 31, 2024
B7-H3 is widely expressed in soft tissue sarcomasMeghan M Lynch, Rusul Al-Marayaty, Farres Obeidin, et al.
Cancer Immunology Research|February 20, 2026
Potent cytotoxic tumor-infiltrating lymphocytes can be generated from immune-excluded chondrosarcomas using regulatable membrane-bound IL15Zheng Ao, Rusul Al-Marayaty, Bülent Arman Aksoy, et al.
Frontiers in Oncology|June 5, 2026
Intratumoral TLR4 agonist therapy elicits antigen-specific T cell clonal expansion in metastatic leiomyosarcoma: a case seriesJessica S Zhang, Juliana C K Ng, Pedro Hermida de Viveiros, et al.
Cancer Discovery|April 22, 2026
BLOCKADE OF TUMOR-INTRINSIC TGF-Β SIGNALING DRIVES HYPERPROGRESSION IN SMALL CELL LUNG CANCERBrett A Schroeder, Chirayu Mohindroo, Anna-Lena Meinhardt, et al.
Pageof 1